Fundz

Arrakis Therapeutics, Inc. reported raising $15 Million in an initial SEC Form D filing, from an offering of $75 Million

PRIVATEApr 18, 2019

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale Apr 18, 2019)

Round Type

Venture

WalthamBiotechnologyHealth CareTherapeutics

Who to call at Arrakis Therapeutics, Inc., and when

A new round usually means Arrakis Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Arrakis Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arrakis Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arrakis Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arrakis Therapeutics, Inc.

Location

830 Winter Street

Waltham, Massachusetts, United States

About

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. The company is building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines focused on cancer and genetically validated targets in other disease areas. Arrakis brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences investors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arrakis Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Arrakis Therapeutics, Inc.'s next move

See what Strategic adds

Arrakis Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.